Background
The Product Development for Vaccines Advisory Committee (PDVAC) was convened for its annual meeting to provide strategic advice and recommendations to WHO, related to vaccines in development. This 4th PDVAC meeting reviewed advances in pathogens where PDVAC has been engaging since 2014, as well as to review several cross-cutting aspects that facilitate acceleration of development of vaccines for LMICs.
As such this meeting focused on vaccine development progress in the pathogen areas of RSV, GBS, GAS, ETEC, Shigella, HSV, HIV, Influenza and TB, and will also discuss cross-cutting topics such as advances in nucleic acid delivery vaccine platforms, the maternal immunization platform, vaccines against antimicrobial resistance (AMR) and consideration for the development of monoclonal antibodies (mAbs) for passive immunization. The goal of this meeting was to discuss progress and challenges in vaccine development, particularly where PDVAC has engaged to date, and to consider future activities and recommendations for WHO’s department of Immunization, Vaccines and Biologicals (IVB) and its Initiative for Vaccine Research (IVR).
Executive summaries of the meetings as well as the agenda, list of participants and presentations can be found below: